Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06175403 · ClinicalTrials.gov registry record · Early Phase 1
A Study of Niacin Regulation
A Early Phase 1 study of Excessive Weight Gain, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 32
- Enrollment target
- 1
- Study location
NCT06175403 is a Early Phase 1 study of Excessive Weight Gain that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 32 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06175403, a Early Phase 1 study of Excessive Weight Gain, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 32 participants
- Enrollment target
- 1
- Study location
Study Summary
Adults who gain most of their excess weight in the abdominal area typically do not respond to things that "turn off" fat cells the same way as lean people. The researchers are trying to understand why fat tissue responds differently in people with different body types.
Conditions Studied
Interventions
- DRUG Niacin
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2024-01-01 |
| Est. Completion | 2027-05-31 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06175403
The ClinicalTrials.gov registry entry for NCT06175403 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Excessive Weight Gain appearing as the primary indexed condition, and to 1 intervention - of which Niacin is the first listed.
NCT06175403 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT06175403 about?
NCT06175403 is a clinical study titled "A Study of Niacin Regulation". Adults who gain most of their excess weight in the abdominal area typically do not respond to things that "turn off" fat cells the same way as lean people. The researchers are trying to understand why fat tissue responds differently in people with different body types.
What is the current status of trial NCT06175403?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 32 participants. The study started on 2024-01-01. Estimated completion is 2027-05-31.
What conditions does trial NCT06175403 study?
This clinical trial studies the following conditions: Excessive Weight Gain.
What interventions are being tested in trial NCT06175403?
The interventions under investigation include: Niacin (DRUG).
Who is sponsoring clinical trial NCT06175403?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06175403 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Excessive Weight Gain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.